Abstract
Advanced-stage melanomas are highly aggressive and refractable to a variety of therapeutic regimens. Low effectiveness of chemotherapy is due to a progressive state of drug resistance. Cisplatin, which is the most effective single agent for the treatment of melanomas, improves the disease free interval of no more than 15% of the melanoma-bearing patients. Neuroectodermal tumors as melanom…